Создана тест-система для выявления рака на ранней стадии по анализу крови

Учёные тестируют разработку для диагностики рака предстательной железы

Scientists from Ural Federal University have created an innovative test system capable of detecting cancer in its early stages. This method is based on blood analysis and is currently undergoing testing for the diagnosis of prostate cancer.

According to the creators of the test system, the diagnosis can be carried out during a medical examination or independently by submitting an analysis. As experts explain, the new test system has high reliability — it analyzes molecular markers — and surpasses existing analogues.
UrFU

Scientists have proposed a new method that allows detecting changes in the metabolism of biomarkers in the blood. Currently, this method is being tested for the early diagnosis of prostate cancer.

As reported by the university, one of the existing analogues is a test system used for the diagnosis of gastroenterological and pulmonary diseases. It is based on gas chromatography. However, as the scientists explained, this method does not allow detecting early stages of oncological diseases.

The researchers plan to expand the work and include other types of cancer. They want to teach the system to accurately determine the stage and aggressiveness of the disease. By 2027, they hope to bring their development to market.

Earlier www1.ru reported that Russian scientists are working on creating sensors that will allow diagnosing diseases by human breath. These sensors have high sensitivity and are able to capture even minor changes in the composition of exhaled air.

Read materials on the topic:

Defeated cancer?: A revolutionary vaccine against all types of cancer has been developed in Russia

In Novosibirsk, an installation was created for the treatment of the most complex types of cancer

The only drug in Russia against cancer based on a virus has passed the first tests

Important stage in cancer treatment: Rosatom has patented a new method for separating radium, actinium and thorium

Breakthrough in oncology: a new Russian radiopharmaceutical "Rakurs" has been created for the treatment of prostate cancer